OncologyOnline.net

Oncology Xagena

Search results for "Anemia"

Erythropoietin treatment for anemia may reduce the risk for blood transfusions and improve hematologic response in cancer patients, but evidence that the treatment affects survival is inconclusive. ...


A joint interim analysis of two studies of Trastuzumab ( Herceptin ) in early-stage breast cancer showed that HER2-positive breast cancer patients receiving Herceptin plus chemotherapy had a 52 perce ...


A study suggests that Aranesp ( Darbepoetin alfa ) administered every three weeks with intravenous ( IV ) iron has the potential to further enhance the effectiveness of increasing patient hemoglobin ...


A study suggests that Aranesp ( Darbepoetin alfa ) administered every three weeks with intravenous ( IV ) iron has the potential to further enhance the effectiveness of increasing patient hemoglobin ...


Researchers at the University of California - Los Angeles ( UCLA ) have defined conditions associated with disabling fatigue that persists for years in almost a third of breast cancer survivors. Th ...


Researchers, at Oregon Health & Science University, wanted to know if depriving men of testosterone actually keeps cancer from spreading beyond the prostate. What they found is that men who have local ...


The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show Temsirolimus ( Torisel ) improved overall survival when co ...


A new study by Northwestern University's Feinberg School of Medicine has shown that cancer patients take drugs to boost their red blood cells, called erythropoiesis-stimulating agents ( ESAs ), actual ...


New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus ( RAD001 ) significantly delays cancer progression in patients with m ...


Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called "erythropoiesis-stimulating agents" ( ESAs ) to treat anemia in so ...


The safety and maximum tolerated dose ( MTD ) of Sunitinib malate( Sutent ) in combination with Bevacizumab ( Avastin ) has been assessed in patients with metastatic renal cell carcinoma ( mRCC ) in a ...


In patients with high-risk breast cancer, addition of the erythropoiesis-stimulating agent ( ESA ) Epoetin alfa to the chemotherapy regimen may help avoid the decrease in hemoglobin levels and resulti ...


The FDA ( Food and Drug Administration ) has approved Xofigo ( Radium Ra 223 dichloride; Radium-223 ) to treat men with symptomatic late-stage castration-resistant prostate cancer that has spread to b ...


Results from the pivotal KEYNOTE-010 study, the first study of its kind to evaluate the potential of an immunotherapy compared to chemotherapy based on prospective measurement of PD-L1 expression in p ...


The results for Nivolumab ( Opdivo ) in the cohort of patients with metastatic urothelial cancer ( n=78 ), the most common type of bladder cancer, after Platinum-based therapy from CheckMate -032, a p ...